Free Trial

Cronos Group (NASDAQ:CRON) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Cronos Group logo with Medical background

Cronos Group (NASDAQ:CRON - Get Free Report) released its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.01, Zacks reports. Cronos Group had a negative return on equity of 2.56% and a negative net margin of 42.65%. The business had revenue of $33.62 million during the quarter, compared to the consensus estimate of $45.44 million.

Cronos Group Stock Down 0.7%

Shares of CRON traded down $0.02 during trading hours on Thursday, hitting $2.05. The company had a trading volume of 416,394 shares, compared to its average volume of 1,324,564. Cronos Group has a 52-week low of $1.60 and a 52-week high of $3.14. The firm has a market cap of $788.16 million, a P/E ratio of -15.73, a P/E/G ratio of 1.74 and a beta of 1.06. The stock's 50 day moving average price is $1.82 and its 200 day moving average price is $1.94.

Cronos Group Company Profile

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Read More

Earnings History for Cronos Group (NASDAQ:CRON)

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines